AzTrials
AzTrials

Surgery, ColorectalCLvsCDNCT06980610

A Randomized Open Controlled Clinical Trial Comparing the Mean Healing Time With Collatamp Versus Directed Healing in Digestive Stoma Closures

A study testing digestive stoma closures in people with Surgery, Colorectal, run by Central Hospital, Nancy, France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The process of directed healing is a slow one, not without any constraints for patients. In contact with the intestinal flora during the stoma time, the tissues harboring digestive bacteria do not allow direct skin closure without the risk of complications during the restoration of digestive continuity after having to… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Surgery, Colorectal
What is being tested?
digestive stoma closures
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
No sites listed yet
Study dates
15 May 2025to 30 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Person having received full information on the organization of the research and having signed their informed consent
  • Patients aged 18 and over
  • Patients requiring ileostomy or colostomy closure, or restoration of digestive continuity
  • Person affiliated with a social security scheme or beneficiary of such a scheme

Who cannot join

  • Patient suffering from an immune deficiency (which would alter the healing process)
  • Patient unable to complete the questionnaire
  • Patient with a known intolerance, hypersensitivity, or allergy to aminoglycosides or bovine collagen
  • Patient suffering from myasthenia gravis
  • Woman of childbearing age without effective contraception
  • Person referred to in Articles L. 1121-5, L. 1121-7, and L. 1121-8 of the French Public Health Code
Show all 10Show fewer
  • Pregnant woman, woman in labor, or breastfeeding mother
  • Minor (non-emancipated)
  • Adult subject to a legal protection measure (guardianship, curatorship, or legal protection)
  • Adult unable to express consent . Person deprived of liberty by a judicial or administrative decision, person receiving psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Matthias MHM Hoeffel-Morgenthaler contact

+33770058922

matt.mhm@sfr.fr

About this study

Official title: A RANDOMIZEZ OPEN CONTROLLED CLINICAL TRIAL COMPARING THE MEN HEALING TIME WITH COLLATAMP VERSUS DIRECTED HEALING IN DIGESTIVE STOMA CLOSSURES

The process of directed healing is a slow one, not without any constraints for patients. In contact with the intestinal flora during the stoma time, the tissues harboring digestive bacteria do not allow direct skin closure without the risk of complications during the restoration of digestive continuity after having to perform an ileal or colonic stoma. Collatamp interposition would allow direct wound closure without additional complications. Various studies have compared directed healing and direct skin closure during stoma closure/restoration of continuity. Overall, directed healing reduces the risk of infection, abscesses, and surgical time, but results in greater constraints for the patient, i.e., longer healing time, more pain, and a poorer cosmetic result compared to direct skin closure.

Being tested
digestive stoma closures
Keywords
SURGERY,, digestive stoma closures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • digestive stoma closuresProcedure or surgery

    Both surgical techniques (Collatamp interposition and directed healing) are routinely used in the CVMC and Digestive Cancer Surgery departments for stoma closure or restoration of digestive continuity. The choice of technique is at the surgeon\'s discretion.

    Specific procedures related to the research:

    Procedures that differ from standard management are randomization and patient completion of a questionnaire.

Study groups in NCT06980610
Study groupRoleWhat they receive
COLLATAMPExperimentalThe strategy under research is the surgical technique with Collatamp interposition between the musculoaponeurotic plane and the cutaneous plane during stoma closures.
Receives: Procedure: digestive stoma closures
directed healingActive comparatorThe strategy used as a reference is the surgical technique of directed healing, with the use of an Algosteril wick.
Receives: Procedure: digestive stoma closures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time until complete healing expressed in days

    Duration of participation of the person participating in the research (including the follow-up period): 6 months maximum

    Duration of statistical analysis and provision of the final report:

    12 months

    Measured: 6 months maximum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2025
  2. Study start15 May 2025 (estimated)
  3. Primary completion30 Aug 2027 (estimated)
  4. Study completion30 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Interventional research with minimal risks and constraints, not involving a product mentioned in Article L. 5311-1 of the CSP
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06980610
Sponsor's protocol ID
2024-A02240-47
Acronym
CLvsCD
Status last verified
May 2025
First submitted
19 May 2025
Last updated
20 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing digestive stoma closures in people with Surgery, Colorectal, run by Central Hospital, Nancy, France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 May 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Matthias MHM Hoeffel-Morgenthaler (+33770058922, matt.mhm@sfr.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time until complete healing expressed in days (time frame: 6 months maximum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in